Microarray analyses revealed reduced PCAF mRNA levels in several types of cancer, including colon, lung, and bladder [236], which was supported by immunohistochemical data showing decreased PCAF protein expression in human intestinal type gastric cancer and colorectal tumors [236,237]. This evidence concerns the gene KAT2B and gastric cancer.